Retrospective Real-World Outcomes for Patients With ALK-Rearranged Lung Cancer Receiving ALK Receptor Tyrosine Kinase Inhibitors - Concepedia

Concepedia

Publication | Open Access

Retrospective Real-World Outcomes for Patients With ALK-Rearranged Lung Cancer Receiving ALK Receptor Tyrosine Kinase Inhibitors

DOI Full Paper Access

20

Citations

38

References

2021

Year

A.J. Gibson, Adrian Box, Michelle L. Dean, A. Elegbede, Desirée Hao, Randeep Sangha, D. Gwyn Bebb

JTO Clinical and Research Reports

References

	Year	Citations

Page 1